Neurol. praxi 2020; 21(Suppl G) | DOI: 10.36290/neu.2020.121
In the setting of the current global pandemic of SARS-CoV-2 coronavirus infection, manifested in a number of cases by the COVID-19 disease, the fact that this disease may cause - both directly and indirectly - a number of novel neurological complications has been clearly observed and described; moreover, it can negatively affect the lives of patients with an already diagnosed neurological disease. Some sequelae have been described in larger groups of patients while others in the form of case reports only; further possible complications are instead derived analogically from other similar conditions. The present article summarizes available and up-to-date knowledge on the neurological issues due to the SARS-CoV-2 infection. The introduction briefly summarizes the general background of the topic: biological and epidemiological characteristics of the novel type of coronavirus and their infectology implications as well as the human immune response to the novel type of coronavirus. A summary follows of the information on possible complications in discrete neurology subspecialities, not only in terms of neurological involvement as a result of COVID-19, but also in terms of the overall effect of the global pandemic on patients with a pre-existing neurological disease. The individual parts present the current knowledge on COVID-19 with respect to demyelinating diseases, cerebrovascular diseases, peripheral neuropathies, extrapyramidal disorders, and inflammatory diseases of the central nervous system. The conclusion section summarizes neurology-related complications, i.e. olfactory and gustatory dysfunctions, and possible neuropsychiatric complications.
Published: December 1, 2020 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |